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Abstract
BH3 only proteins trigger cell death by interacting with pro- and anti-apoptotic members of the BCL-2 family of proteins.
Here we report that BH3 peptides corresponding to the death domain of BH3-only proteins, which bind all the pro-survival
BCL-2 family proteins, induce cell death in the absence of BAX and BAK. The BH3 peptides did not cause the release of
cytochrome c from isolated mitochondria or from mitochondria in cells. However, the BH3 peptides did cause a decrease in
mitochondrial membrane potential but did not induce the opening of the mitochondrial permeability transition pore.
Interestingly, the BH3 peptides induced mitochondria to undergo fission in the absence of BAX and BAK. The binding of
BCL-XL with dynamin-related protein 1 (DRP1), a GTPase known to regulate mitochondrial fission, increased in the presence
of BH3 peptides. These results suggest that pro-survival BCL-2 proteins regulate mitochondrial fission and cell death in the
absence of BAX and BAK.
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Introduction
The BCL-2 family of proteins are critical regulators in the
process of cell death [1]. Characterized by their conserved BCL-2
Homology (BH) domains, these proteins are divided into groups
that have pro-survival and pro-apoptotic functions. The pro-
apoptotic group is divided into the single BH3 domain containing
proteins and the multi BH3 domains proteins, BAX and BAK [2].
BH3 only proteins activate BAX and BAK to induce the
permeabilization of the outer mitochondrial membrane (MOMP),
and the subsequent release of cytochrome c [3]. In addition to the
physical changes required for the release of cytochrome c, a
remarkable alteration during the process of cell death is that the
interconnected mitochondria network undergoes morphological
changes from long tubular, to short punctiform structures [4]. The
short punctated structures reflect fragmentation of the mitochon-
dria, a process referred to as mitochondrial fission.
The mammalian fission machinery to date consists of DRP1,
FIS1 and OPA-1. FIS1 is distributed throughout the outer
mitochondrial membrane and Dynamin related protein-1 (DRP-
1) is localized in the cytosol [5]. DRP1 and FIS1 control the fission
of outer mitochondrial membrane while OPA1 regulates fusion of
the inner membrane. DRP1 translocate and co-localizes with BAX
on the surface of the outer mitochondrial membrane during early
stages of apoptosis [6]. DRP1 inhibition delays or partially inhibits
cell death suggesting a role for mitochondrial fission in cell death
[7,8]. Furthermore, a small molecule that inhibits DRP-1 prevents
BH3-only protein dependent cytochrome c release in isolated
mitochondria [9]. In contrast other reports indicate that the
downregulaton of hFIS1 or DRP1 prevents mitochondrial fission
but not BAX/BAK dependent cell death during apoptosis [10].
The overexpression of hFIS1 does not induce death in cells devoid
of BAX and BAK [11]. However, these cells still undergo
mitochondrial fragmentation indicating that mitochondrial fission
is distinct from BAX/BAK dependent cell death. Recent studies
further support that fission and cytochrome c induced cell death
are discrete events [12]. Nevertheless, OPA-1 mediated cristae
remodeling is required for cytochrome c release [13]. Thus, the
role of the fission machinery in cell death is complex [14].
Mitochondrial fission is an evolutionarily conserved process and
has been suggested to regulate cell death in C. elegans [15].
Interestingly, in this model organism the multi BH3 proteins BAX
and BAK are not present, and cytochrome c release does not play
a role in initiating cell death [16]. Rather, binding of the BCL-2
like pro-survival protein CED-9, by a BH3-only protein EGL-1, is
the key initiation event in the apoptotic pathway, and induces
mitochondrial fission [15]. The overexpression of a dominant
negative DRP-1 mutant increased survival of cells in this model.
However, recent evidence suggests that the role of DRP1 in cell
death is distinct from its role in mitochondrial fission in C. elegans
[17]. Given the fact that BH3 proteins binding to prosurvival
BCL-2 proteins can regulate both mitochondrial fission and cell
death in C. elegans, here we have uncovered that negating the pro-
survival proteins by BH3 peptides can also lead to mitochondrial
fission and cell death in a mammalian system devoid of BAX and
BAK.
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BH3 peptides induce cell death in the absence of BAX,
BAK and BOK
BAX or BAK are the essential regulators for permeabilization of
the outer mitochondrial membrane. Previous published studies
[3,18], have demonstrated that several death stimuli including
anoxia, growth factor withdrawal, DNA damaging agents fail to
induce cell death in the absence of BAX and BAK. These various
death stimuli likely activate BH3-only proteins which bind and
neutralize a fraction of pro-survival BCL-2 proteins to lower the
threshold for the activation of BAX and BAK. To test negation of
prosurvival BCL-2 proteins in the absence of BAX and BAK can
trigger death, we treated Bax
2/2/Bak
2/2 MEFs with peptides
spanning the BH3 domains of the BH3 only proteins. These peptides
have been previouslydemonstrated to have high binding specificity to
pro-survival proteins [19–21]. These peptides can be administered to
cells at concentrations that arelikelyto bind to a large fraction of pro-
survival BCL-2 proteins. The BH3 peptides BID, BIM and PUMA
are known to bind all BCL-2 pro-survival proteins. By contrast,
NOXABH3peptide specificallybinds MCL-1 and BAD binds BCL-
2, BCL-XL, BCL-w and A1. The BH3 peptides are tagged with 8-D
arginines which allows for rapid uptake by cells (Figure S1).
Treatment with the BID BH3 peptide (100 mM) resulted in similar
levels of cell death as measured by LDH release in wild type and
Bax
2/2/Bak
2/2 MEFs at 24 hours (Figure 1A). As a control, cells
were treated with a mutant BID BH3 peptide in which the conserved
residues leucine and aspartate were mutated to alanine. The
mutation of these two critical amino acids has been previously shown
to disrupt binding to all pro-survival BCL-2 proteins [19,21]. As
predicted, treatment with the mutant BID peptide did not induce cell
death in wild type or Bax
2/2/Bak
2/2 MEFs. The overexpression of
Bcl-XL slightly prevented BID BH3 induced cell death (Figure S2).
BIM or PUMA BH3 peptides also induced cell death in wild type or
Bax
2/2/Bak
2/2 MEFs (Figure 1B). Treatment of wild type and
Bax
2/2/Bak
2/2 MEFs with NOXA or BAD peptides alone did not
induce cell death in either cell lines, whereas the combination of both
NOXAand BAD peptides induced cell deathinwild typeor Bax
2/2/
Bak
2/2 MEFs (Figure 1C). To ensure that the cell death was not due
to high concentration of the peptides, we designed a mutant version of
the BAD peptide, containing two mutations at the conserved residues
leucine and aspartate (mutated to alanine). The mutant BAD peptide
in combination with NOXA peptide did not cause cell death. To
delineate the kinetics of cell death, we treated Bax
2/2/Bak
2/2 MEFs
with BH3 peptides for 1 hour and assessed cell death by propidium
iodide (PI) staining (Figure 1D). Treatment with BID and BIM BH3
peptides resulted in significant cell death in Bax
2/2/Bak
2/2 MEFs
compared to the mutant BID BH3 peptide. In order to rule out that
this finding was not restricted to embryonic fibroblasts, we tested for
PI staining in an epithelial cell line derived from kidneys of BAX and
BAK deficient mouse (referred to as BMK). BMK cells also displayed
significant cell death after 1 hour of BID or BIM peptide treatments
(Figure 1E).
The BCL-2 related ovarian killer (BOK) is another pro-
apoptotic protein similar to BAX and BAK proteins, in that it
contains BH1, BH2 and BH3 domains [22]. In the absence of
BAX and BAK we therefore evaluated whether BOK was
required for BH3 peptide induced cell death. PCR and western
blot analysis both revealed that BOK mRNA and protein were
expressed in the Bax
2/2/Bak
2/2 embryonic fibroblast cells and in
epithelial kidney cells (data not shown). We retrovirally infected
Bax
2/2/Bak
2/2 MEFs with short hairpin RNA against BOK, or a
control shRNA containing drosophilia HIF (DHIF) (Figure 2A).
BID and BIM BH3 peptides induced death in cells containing
shRNA against BOK or DHIF (Figure 2B). Collectively these data
demonstrate that BH3 peptides that can bind to all the pro-
survival BCL-2 proteins can induce cell death independent of
BAX, BAK and BOK.
Caspase inhibition does not inhibit BH3 peptides
induced cell death
Caspases are key effectors of apoptosis. We evaluated whether
the peptide induced cell death was caspase dependent. To assess
whether caspase 9 was involved, we inhibited endogenous caspase-
9o fBax
2/2/Bak
2/2 MEFs by the overexpressing dominant
negative caspase-9 [23]. BID and BIM peptides still induced cell
death in the presence of the dominant negative caspase-9
(Figure 3A). To test whether pan caspase inhibition would prevent
cell death, Bax
2/2/Bak
2/2 MEFs were treated with the pan-
caspase inhibitor quinoline-Val-Asp(ome)-CH2-O-phenoxy (Q-
VD-OPh). BH3 peptides induce cell death in the presence of Q-
VD-OPh (Figure 3B). These results indicate that BH3 peptides
might be activating caspase independent cell death in the Bax
2/2/
Bak
2/2 MEFs. Caspase-independent cell death (CICD) can be
prevented by the overexpression of the glycolytic enzyme
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in the
presence of a pan caspase inhibitor [24]. However, BH3 peptides
still induced cell death in Bax
2/2/Bak
2/2 MEFs overexpressing
GAPDH in the presence of the broad spectrum caspase inhibitor
Q-VD-OPh (Figure 3C and 3D). We also tested whether
autophagy contributed to the BH3 peptide induced cell death.
Autophagy induced cell death can occur in the absence of BAX
and BAK [25]. To test whether Bax
2/2/Bak
2/2 MEFs died by
activating autophagy, we utilized a well characterized inhibitor of
autophagy, 3-methyladenine (3-MA). Bax
2/2/Bak
2/2 MEFs were
pretreated with 3-MA followed by BID BH3 peptide in the
presence of 3-MA. 3-MA did not protect against BID BH3 peptide
cell death (Figure 3E), therefore suggesting that the BH3 peptide
induced cell death in the absence of BAX and BAK was not
mediated by autophagy. Collectively, these experiments demon-
strate that caspases, caspase independent cell death regulated by
GAPDH or autophagy are not likely contributing to the cell death.
BH3 peptides do not cause the release cytochrome c in
Bax
2/2/Bak
2/2 MEFs
To evaluate whether the BID BH3 peptide induces cytochrome c
release, the BID BH3 peptide was added to isolated mitochondria
from wild type and Bax
2/2/Bak
2/2 MEFs. BID BH3 peptide
induced cytochrome c release in the wild type MEFs but not in the
Bax
2/2/Bak
2/2 MEFs. The mutant BID BH3 peptide did not
cause cytochrome c release in either wild type or Bax
2/2/Bak
2/2
isolated mitochondria (Figure 4A). Because cytochrome c was not
released from the isolated mitochondria of Bax
2/2/Bak
2/2 MEFs,
we further evaluated whether cytochrome c was released in live
cells. Wild type and Bax
2/2/Bak
2/2 MEFs were transfected with
cytochrome c tagged with GFP and time lapse microscopy was
performed. While the mutant BID peptide did not display release of
cytochrome c from the mitochondria, both BID and BIM peptides
induced cytochrome c release in the wild type cells as demonstrated
by the diffusion pattern of the GFP throughout the cell (Figure 4B).
However, Bax
2/2/Bak
2/2 MEFs treated with BID and BIM
peptides, did not display diffused GFP within the cell, which is
indicative of a lack of cytochrome c release (Figure 4C).
Western blot analysis further confirmed that the mutant BID,
BID or BIM BH3 peptides did not induce the release of
cytochrome c in Bax
2/2/Bak
2/2 MEFs as detected by the
retention of cytochrome c in the mitochondrial pellet fraction
BAX/BAK Independent Cell Death
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BID or BIM BH3 peptides but not the mutant BID BH3 peptide
induced the release of cytochrome c into the cytosol as detected by
the presence of cytochrome c in the supernatant fraction
(Figure 5A). This data further indicate that Bax
2/2/Bak
2/2
MEFs cell death is not through the release of cytochrome c.
Figure 1. BH3 peptides induce cell death in Bax
2/2/Bak
2/2 MEFs. (A) Percentage of cell death measured by LDH release at 24 hours following
treatment of wild type and Bax
2/2/Bak
2/2 MEFs with BID or mutant BID BH3 peptide (50 mM and 100 mM). Mean values6SEMs of 3 independent
experiments are shown. (B) Percentage of LDH release from wild type and Bax
2/2/Bak
2/2 MEFs after treatment with BIM (40 mM and 80 mM) or PUMA
(50 mM and 100 mM) BH3 peptide for 24 hours. Mean values6SEMs of 3 independent experiments are shown. (C) Wild type and Bax
2/2/Bak
2/2 MEFs
were treated with NOXA BH3 peptide (75 mM), BAD BH3 peptide (30 mM), NOXA BH3 peptide (75 mM)+BAD BH3 peptide (30 mM) or NOXA BH3
peptide (75 mM)+mutant BAD BH3 peptide (30 mM). Cell death was measured by LDH released at 24 hours. Mean values6SEMs of 3 independent
experiments are shown. (D and E) Percentage of PI positive Bax
2/2/Bak
2/2 MEFs and Bax
2/2/Bak
2/2 Baby Mouse Kidney (BMK) epithelial cells after
1 hour of treatment with BID BH3 peptide (100 mM), mutant BID BH3 peptide (100 mM) or BIM BH3 peptide (80 mM). Mean values6SEMs of 3
independent experiments are shown.
doi:10.1371/journal.pone.0005646.g001
BAX/BAK Independent Cell Death
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membrane potential in Bax
2/2/Bak
2/2 MEFs
independent of the permeability transition pore
Typically, cells undergo a loss of mitochondrial membrane
potential upon cytochrome c release [26]. To assess mitochondrial
membrane potential in wild-type or Bax
2/2/Bak
2/2 MEFs, we
loaded cells with fluorescent dye tetramethylrhodamine ester
(TMRE). BIM and BID BH3 peptide induced a decrease in
TMRE fluorescence compared to the mutant BID BH3 peptide in
both wild-type or Bax
2/2/Bak
2/2 MEFs indicative of mitochon-
drial membrane depolarization (Figure 6A and B).
To test whether the permeability transition pore (PTP) is
responsible for the loss in mitochondrial membrane potential, we
utilized the release of calcein from the mitochondria. Bax
2/2/
Bak
2/2 MEFs were loaded with calcein and cobalt chloride, which
quenches calcein signal in the cytosol. Thus the remaining signal is
calcein retained in the mitochondria. Calcein is released upon PTP
opening with agents such as ionomycin. BID BH3 peptide treated
Bax
2/2/Bak
2/2 MEFs had comparable mitochondrial calcein
retention to that of DMSO and mutant BID treated Bax
2/2/
Bak
2/2 MEFs, which could be decreased to baseline upon the
addition of ionomycin (Figure 6C). We further assessed for the
involvement of the PTP in the peptide induced cell death by its direct
inhibition using 1 mM of cyclosporine A (CsA). Inhibiting the PTP
with CsA did not protect Bax
2/2/Bak
2/2 MEFs from peptide
induced cell death (Figure 6D). We confirmed that 1 mMC s Aw a s
efficient at inhibiting the permeability transition pore by assessing for
calcein retention in the mitochondria following treatment with
ionomycin (Figure S3). Calcium isone of the major regulators of PTP
opening. Wetested whether calcium was involved in the BH3 peptide
induced cell death in the Bax
2/2/Bak
2/2 MEFs. The calcium
chelator BAPTA-AM did not prevent BID or BIM BH3 peptide
induced cell death (Figure 6E). These data suggest that BH3 peptides
induced mitochondrial membrane depolarization without invoking
PTP opening.
BH3 peptides induce mitochondrial fragmentation in
Bax
2/2/Bak
2/2 MEFs
We observed a change in mitochondrial morphology from long
tubular to a small punctuated pattern of cytochrome c-GFP in
Bax
2/2/Bak
2/2 MEFs (Figure 4C). To further confirm these
morphological changes in mitochondria, Bax
2/2/Bak
2/2 MEFs
were stained with a fluorescent dye, Mitotracker CMX-ROS.
Bax
2/2/Bak
2/2 MEFs treated with mutant BID BH3 peptide
displayed normal mitochondrial dynamics, and mitochondria
appeared tubular and elongated (Figure 7A top panel). By
contrast, Bax
2/2/Bak
2/2 MEFs treated with the BID and BIM
BH3 peptides displayed short, spherical mitochondria (Figure 7A
middle and bottom panel respectively), indicative of mitochondrial
fragmentation. Bax
2/2/Bak
2/2 MEFs treated with BAD or
NOXA BH3 peptides, did not reveal any changes in the
mitochondrial morphology and maintained the elongated tubular
structures (Figure 7B). However, the combination of BAD and
NOXA peptides induced a change in the mitochondrial
morphology from tubular and elongated structures to smaller
spherical structures (Figure 7B) similar to those observed with BID
and BIM. As a control, the combination of NOXA with a mutant
BAD peptide did not induce changes in mitochondrial structure
(Figure 7B, bottom panel). These data demonstrate that
mitochondria underwent fragmentation only when the pro-
survival proteins were neutralized with BH3 peptides.
To further confirm that the change in mitochondrial morphol-
ogy was not dependent on peptide uptake by the cell, we
performed microinjection of BID BH3 and mutant BID BH3
peptides that did not contain the 8-D arginine sequence in
combination with FITC dextran as a marker for injected cells. We
captured images of cells that were injected next to non injected
cells to show the difference in mitochondrial morphology. As
shown in figure 8A when Bax
2/2/Bak
2/2 MEF were microin-
jected with the BID BH3 peptide, the mitochondrial morphology
changed from long tubular structures to small spherical structures,
while the mutant BID BH3 peptide did not induce a change in
mitochondrial structure (Figure 8B) upon microinjection.
BH3 peptides induce a decrease in mitochondrial aspect
ratio of Bax
2/2/Bak
2/2 MEFs
We further verified the change in mitochondrial morphology
using electron microscopy. Electron micrographs revealed that
Bax
2/2/Bak
2/2 MEFs treated with the mutant BID BH3 peptide
contained more elongated mitochondria (Figure 9A) compared to
cells treated with BID BH3 peptide, whereby the mitochondria
were smaller and appeared more spherical in structures
(Figure 9B). Quantitative analysis was performed by measuring
the aspect ratio (major axes divide by the minor axes) of the
Figure 2. BH3 peptides induce cell death in the absence of BAX, BAK and BOK. (A) Western blot demonstrating levels of BOK protein levels
in Bax
2/2/Bak
2/2 MEFs stably transfected with shRNA against BOK. Stable Bax
2/2/Bak
2/2 MEFs expressing a shRNA hairpin against D. melanogaster
HIF (dHif) served as a control. (B) Bax
2/2/Bak
2/2 MEFs stably transfected with a shRNA against BOK or dHIF were treated with BID BH3 peptide
(100 mM), mutant BID BH3 peptide (100 mM) or BIM BH3 peptide (80 mM) and after 1 hour the percentage of PI positive cells was analyzed by FACs
analysis. Mean values6SEMs of 3 independent experiments are shown.
doi:10.1371/journal.pone.0005646.g002
BAX/BAK Independent Cell Death
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2/2/Bak
2/2
MEFs treated with BID BH3 peptide had a reduced aspect ratio
compared to the mutant BID BH3 peptide (Figure 9C). These
results further confirm that the mitochondria were indeed
undergoing fragmentation, resembling that of mitochondrial
fission.
Figure 3. Caspase inhibition does not inhibit BH3 Peptides induced cell death. (A) Bax
2/2/Bak
2/2 MEFs stably expressing a dominant
negative caspase 9, or empty vector were treated with indicated peptides and after 1 hour the percentage of PI positive cells was analyzed by FACs
analysis. Mean values6SEMs of 3 independent experiments are shown. (B) Bax
2/2/Bak
2/2 MEFs were treated with Q-VD-OPh (50 mM, broad range
caspase inhibitor) for 1 hour prior to adding BID peptide (100 mM) for 1 hour. Percentage cell death was determined by assessing for cell staining
positive for propidium iodine by flow cytometry. Mean values6SEMs of 3 independent experiments are shown. (C) Bax
2/2/Bak
2/2 MEFs expressing
GAPDH, or control empty vector were treated with indicated peptides in the presence or absence of Q-VD-OPh (50 mM) for 1 hour. Percentage of PI
positive cells was analyzed by flow cytometry. (D) Western blot demonstrating levels of GAPDH protein over-expression in Bax
2/2/Bak
2/2 MEFs.
GAPDH was tagged to V5, therefore both endogenous and overexpressed levels could be identified. Empty vector was used as a transfection control.
Bottom panel show tubulin levels, a loading control. (E) Bax
2/2/Bak
2/2 MEFs were treated with 3-Methyladenine (10 mM, autophagy inhibitor) for
1 hour prior to adding BID BH3 peptide (100 mM) or mutant BID BH3 peptide (100 mM) for 1 hour. Percentage cell death was determined by
assessing for cell staining positive for propidium iodine by flow cytometry. Mean values6SEMs of 3 independent experiments are shown.
doi:10.1371/journal.pone.0005646.g003
BAX/BAK Independent Cell Death
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2/2/Bak
2/2 isolated mitochondria or MEFs. (A) Isolated
mitochondria of wild type and Bax
2/2/Bak
2/2 MEFs were treated with BID BH3 peptide (100 mM) or mutant BID BH3 peptide (100 mM). Cytochrome c
released from isolated mitochondria was determined by ELISA read at 450 nm with wavelength correction at 540 nm. Mean values6SEMs of 3
independent experiments are shown. (B and C) Wild type MEFs and Bax
2/2/Bak
2/2 MEFs respectively were stably transfected with cytochrome c
tagged with GFP and time lapse microscopy was performed to assess for cytochrome c release upon treatment with BID BH3 peptide (100 mM),
mutant BID BH3 peptide (100 mM) or BIM BH3 peptide (80 mM) Pictures were taken prior to peptide treatment and at 1 minute intervals post peptide
treatment.
doi:10.1371/journal.pone.0005646.g004
BAX/BAK Independent Cell Death
PLoS ONE | www.plosone.org 6 May 2009 | Volume 4 | Issue 5 | e5646BH3 peptides induce an increase in BCL-XL binding to
dynamin-related protein 1 (DRP1)
Previous published findings showed that the pro-survival protein
BCL-XL i n t e r a c t sw i t ht h ef i s s i o nm a c h i n e r yp r o t e i nD R P 1a n dt h a t
this interaction increases the GTPase activity of DRP1 [27]. We
therefore investigated whether BCL-XL and DRP1 interact upon
treatment with BH3 peptides in Bax
2/2/Bak
2/2 MEFs. Bax
2/2/
Bak
2/2 MEFs overexpressing FLAG-tagged BCL-XL were treated
with peptides, followed by immunoprecipiation with a FLAG
antibody and immunoblotted for DRP1 (Figure 10A). Treatment
with the BID BH3 peptide caused a twofold increase in the
interaction between DRP-1 and BCL-XL compared to cells treated
with the mutant BID BH3 peptide (Figure 10B). To test whether
DRP1 is required for the BH3 peptide induced cell death, Bax
2/2/
Bak
2/2 MEFs were infected with a retrovirus containing a dominant
negative DRP1(K38A). BIM or BID BH3peptide induced celldeath
in Bax
2/2/Bak
2/2 MEFs expressing the dominant negative DRP1
(Figure 10C). The dominant negative DRP1 also failed to prevent
staurosporine induced cell death in wild-type MEFs (Figure 10D).
Dominant negative DRP-1 also did not prevent mitochondrial fission
upon treatment with BH3 peptides (data not shown). Furthermore,
the small molecule inhibitor of DRP1, mdivi-1, also did not inhibit
cell death in the presence of BIM BH3 peptides (Figure 10E).
However, Mdivi-1 did partially inhibit staurosporine induced cell
death in wild-type MEFs (Figure 10F). These results suggestthat BH3
peptides bind to pro-survival BCL-2 proteins to engage the DRP-1
dependent fission machinery in the absence of BAX and BAK.
However, the DRP1 induced fission is not required for BH3 peptide
induced cell death. There might be other yet unidentified regulators
of fission machinery that might participate in the BH3 peptide
induction of cell death.
Discussion
The BCL-2 protein BAX and BAK induce the mitochondrial
outer membrane permeabilization (MOMP) for the release of
cytochrome c. Current models indicate that the BH3 only
proteins, a subset of the BCL-2 family proteins, are initiators of
BAX/BAK dependent MOMP. How BAX and BAK are
activated to induce MOMP remains controversial. One model
states that a subset of BH3-only proteins bind pro-survival BCL-2
proteins to release other BH3 only proteins that can directly
activate BAX/BAK [21,28]. By contrast, another model states
that binding of all pro-survival BCL-2 family proteins by BH3 only
proteins is sufficient to activate BAX/BAK [20,29]. A common
feature of the two models is that negation of pro-survival BCL-2
family members is required for BAX/BAK to induce MOMP.
Here we demonstrate that cell death can be induced in the absence
of the multi BH3 proteins BAX and BAK, upon treatment with
peptides corresponding to the BH3 domain of BH3 only pro-
apoptotic proteins. Previous studies have characterized that the
BH3 peptides indeed bind to pro-survival proteins with strong
affinities and specificities. Our data indicates that the BH3
peptides can induce cell death in the combined absence of BAX
and BAK through binding of all the pro-survival proteins.
Our observation is reminiscent of the death process observed in
C. elegans, whereby the neutralization of the pro-survival protein
CED-9 by the BH3 only protein EGL-1 can induce both
mitochondrial fission and cell death [15]. C. elegans do not contain
BAX or BAK. A recent report indicates that mitochondrial
fragmentation and cell death are distinct events in C. elegans [17].
In mammalian cells where BAX and BAK are present, the
neutralization of pro-survival proteins by BH3 only proteins
triggers rapid activation of BAK and BAK to induce MOMP.
However, in mammalian cells deficient for BAX and BAK, we can
unmask the evolutionarily conserved mechanism of cell death, in
which BH3 only proteins bind pro-survival BCL-2 proteins to
initiate both mitochondrial fission and cell death in the absence of
BAX and BAK.
Although our findings seem to be in contradiction with previous
data that indicate that Bax
2/2/Bak
2/2 MEFs do not undergo cell
Figure 5. BH3 Peptides do not induce release of cytochrome c in Bax
2/2/Bak
2/2 MEFs. (A and B) Wild type and Bax
2/2/Bak
2/2 MEFs were
treated with DMSO, Mutant BID BH3 peptide (100 mM), BID BH3 peptide (100 mM) or BIM BH3 peptide (100 mM) for 1 hour. Cytochrome c localization
was assessed in the mitochondrial and cytosolic fractions by Western Blot analysis. Cytochrome c oxidase subunit 1 (COX-1) antibody was used as a
control to ensure proper fractionation and loading of mitochondrial pellet.
doi:10.1371/journal.pone.0005646.g005
BAX/BAK Independent Cell Death
PLoS ONE | www.plosone.org 7 May 2009 | Volume 4 | Issue 5 | e5646Figure 6. BH3 Peptides induces a decrease in mitochondrial membrane potential but does not engage the Permeability Transition
Pore. (A and B) Quantification of TMRE release from wild type and Bax
2/2/Bak
2/2 MEFs respectively, as an output of mitochondrial membrane
depolarization. Mitochondria were loaded with 50 nM TMRE and treated BID BH3 peptide (100 mM), mutant BID BH3 peptide (100 mM) or BIM BH3
BAX/BAK Independent Cell Death
PLoS ONE | www.plosone.org 8 May 2009 | Volume 4 | Issue 5 | e5646death upon overexpression of BH3 only proteins, the difference is
that the BH3 peptides might bind to a larger pool of pro-survival
BCL-2 family proteins. Alternatively, the BH3 peptides can
perhaps access pro-survival proteins better than endogenous BH3
proteins. The BH3 peptides have been extensively utilized
previously to probe both specificities of BH3 proteins binding to
prosurvival BCL-2 proteins and the mechanism by which BH3
proteins induce release of cytochrome c [19–21,28]. Previous data
indicate that expression of BH3 only protein BIM which can bind
all the pro-survival BCL-2 family proteins can induce cell death in
Figure 7. BH3 peptides induce mitochondrial fragmentation of Bax
2/2/Bak
2/2 MEFs. (A) Mitochondria of Bax
2/2/Bak
2/2 MEFs were stained
with Mitotracker Red CMXRos (50 nM) and time lapse microcopy was performed. Pictures were taken prior to and at 1 minute intervals following
treatment with 100 mM of mutant BID, BID and BIM BH3 peptides. (B) Time lapse microscopy of Bax
2/2/Bak
2/2 MEFs stained with Mitotracker
RedCMXRos (50 nM). Cells were treated with sensitizer peptides, NOXA (75 mM) or BAD BH3 peptide (30 mM) alone, or in combination. The
combination of NOXA (75 mM) and mutant BAD BH3 peptide (30 mM) was also analyzed.
doi:10.1371/journal.pone.0005646.g007
peptide (80 mM). Time lapse imaging was taken at 20 second intervals. Mean values6SEMs of 3 independent experiments are shown. (C) Bax
2/2/
Bak
2/2 MEFs treated for 1 hour with DMSO, BID BH3 peptide (100 mM), mutant BID BH3 peptide (100 mM), followed by 100 nM of calcein-AM
labeling (and quenched with 0.4 mM Cobalt Chloride) in the presence or absence of ionomycin (500 nM). Mean calcein fluorescence was measured at
530 nm by flow cytometry. Results are expressed as mean values6SEMs of 5 independent experiments. (D) Bax
2/2/Bak
2/2 MEFs were treated with
cyclosporine A (1 mM, CsA) and treated with BID BH3 peptide (100 mM), mutant BID BH3 peptide (100 mM) or BIM BH3 peptide (80 mM) for 1 hour.
Percentage cell death was determined by assessing for PI staining by flow cytometry. Mean values6SEMs of 3 independent experiments are shown.
(E) Bax
2/2/Bak
2/2 MEFs were treated with BAPTA-AM (5 mM) for 15 minutes prior to adding BID BH3 peptide (100 mM), mutant BID BH3 peptide
(100 mM) or BIM BH3 peptide (80 mM) for 1 hour. Percentage cell death was determined by assessing for cell staining positive for propidium iodine by
flow cytometry. Mean values6SEMs of 3 independent experiments are shown.
doi:10.1371/journal.pone.0005646.g006
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the BH3 only protein BAD which only binds a subset of pro-
survival BCL-2 family proteins (BCL-2, BCL-XL, A1, BCL-w)
does not induce cell death [30,31]. In accordance with these
previous studies we also observe that expression of BIM protein
and not BAD protein induces BAX/BAK dependent cell death
(data no shown). In contrast, treating the cells with BIM BH3
peptide induces cell death even in the absence of BAX and BAK.
Other BH3 peptides that can bind all the pro-survival proteins
such as BID and PUMA can also induce cell death even in the
absence of BAX and BAK. Additionally, neither the NOXA BH3
peptide, which only binds the pro-survival protein MCL-1, nor the
BAD BH3 peptide, which binds only BCL-2, BCL-XL, A1 and
BCL-w, failed to induce cell death. However, the combination of
NOXA and BAD BH3 peptides did induce cell death in the
absence of BAX/BAK. Furthermore, as controls throughout our
study, we utilized when appropriate, either a mutant BID BH3
peptide or mutant BAD BH3 peptides. These peptides contain two
amino acid mutated to alanine thus disrupting their binding to
pro-survival BCL-2 family proteins [19,21]. The mutation still
allowed for efficient transport of the peptides in cells. These
controls indicate that the BH3 peptide killing of Bax
2/2/Bak
2/2
cells is not due non-specific effects such as the 8 D-arginine
residues utilized to transport the peptides across cell membranes.
Also, these observations in MEFs were corroborated utilizing a
BAX/BAK deficient epithelial cell line.
The BH3 peptides did not result in any detectable cytochrome c
release from mitochondria isolated from Bax
2/2/Bak
2/2 cells or
from intact Bax
2/2/Bak
2/2 cells. These peptides simply do not
permeabilize membranes or else they would have released
cytochrome c even in the absence of BAX/BAK. These results
are consistent with previous findings that BH3 proteins or peptides
require BAX/BAK for cytochrome c release [3,21]. However, the
BH3 peptides resulted in depolarization of the mitochondrial
Figure 8. Micro-injection of BH3 peptides induces mitochondrial fragmentation of Bax
2/2/Bak
2/2 MEFs. (A and B) Mitochondria of Bax
2/2/
Bak
2/2 MEFs were stained with Mitotracker Red CMXRos (50 nM) followed by microinjection of 100 mM BID (A) or mutant BID peptide (B) that does not
contain 8D-arginines. Injected cells were tracked by dextran FITC.
doi:10.1371/journal.pone.0005646.g008
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mitochondrial membrane potential can be an initiating event for
induction of cell death [32]. Previous studies have indicated that
mitochondrial fission can result in loss of mitochondrial membrane
potential [7]. Depolarized mitochondria as a result of excessive
fission have lower probability to refuse, which therefore leads to an
Figure 9. BH3 peptides induce a decrease in mitochondrial aspect ratio of Bax
2/2/Bak
2/2 MEFs. (A) Electron micrograph at 20006of
Bax
2/2/Bak
2/2 MEFs treated with mutant BID BH3 peptide (100 mM). 60006magnification of indicated area. (B) Electron micrograph at 20006of
Bax
2/2/Bak
2/2 MEFs treated with BID BH3 peptide (100 mM). Indicated regions are at 60006magnification. (C) Mitochondrial length was determined
by analyzing the aspect ratio (AR), (length of major axes/ minor axes). BID treatment resulted in a decrease in AR ratio. P value=0.0001. Student’s
unpaired t test was used to assess for statistical significance.
doi:10.1371/journal.pone.0005646.g009
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PLoS ONE | www.plosone.org 11 May 2009 | Volume 4 | Issue 5 | e5646Figure 10. BH3 peptides induce an increase in Bcl-XL binding to dynamin-related protein 1 (DRP1). (A) Immunoblot of
coimmunoprecipitation of BCL-XL and DRP1. Bax
2/2/Bak
2/2 MEFs overexpressing Flag BCL-XL were treated with DMSO, BID BH3 peptide
(100 mM) or mutant BID BH3 peptide (100 mM). Flag antibody was used for immunoprecipitation. (B) Relative amounts of DRP1 binding to BCL-XL
following treatment of mutant BID BH3 peptide (100 mM) or BID BH3 peptides (100 mM). BID BH3 peptide induced a two fold increase in DRP1
binding to BCL-XL. P value=0.0122. Student’s unpaired t test was used to assess for statistical significance. (C) Bax
2/2/Bak
2/2 MEFs overexpressing
DN DRP1 or empty pBabe construct as a control were treated for 1 hour with DMSO or indicated peptides. Percentage of cell death was determined
by LDH release. Mean values6SEMs of 3 independent experiments are shown. (D) Wild Type MEFs overexpressing DN DRP1 or empty pBabe
construct as a control were treated for 16 hours with DMSO or staurosporine (1 mM STS). Percentage of cell death was determined by assessing for PI
positive cells by flow cytometry. Mean values6SEMs of 3 independent experiments are shown. (E) Bax
2/2/Bak
2/2 MEFs were pretreated with the
mitochondrial fission inhibitor mdivi-1 (100 mM) for 30 minutes followed by 1 hour treatment with of BIM BH3 peptide (80 mM). Percentage of cell
death was assessed by PI staining. Mean values6SEMs of 3 independent experiments are shown. (F) Wild type MEFs were pretreated with mdivi-1
(100 mM) for 30 minutes followed by 16 hour treatment with staurosporine (1 mM STS). Percentage of cell death was assessed by LDH release. Mean
values6SEMs of 3 independent experiments are shown.
doi:10.1371/journal.pone.0005646.g010
BAX/BAK Independent Cell Death
PLoS ONE | www.plosone.org 12 May 2009 | Volume 4 | Issue 5 | e5646accumulation of fragmented dysfunctional mitochondria [33].
Indeed, we observed that following BH3 peptides treatment, the
mitochondrial of Bax
2/2/Bak
2/2 MEFs undergo fission as
assessed by staining mitochondria with a fluorescent dye or
electron microscopy. Thus, we propose that BH3 peptides induce
mitochondrial fission resulting in mitochondrial membrane
depolarization in the absence of BAX/BAK.
The role of mitochondrial fission during the process of cell death
still remains unclear [14]. An existing idea is that fragmentation of
the mitochondria is important for the release of apoptogenic
factors such as cytochrome c to induce cell death [7,8,34]. This is
further supported by the observation that OPA-1 mediated cristae
remodeling is required for efficient cytochrome c release. Our data
indicate that the mitochondria can undergo fission without the
release of cytochrome c, indicating that the two processes are
discrete events. This observation is consistent with a recent study
by Sheridan et al demonstrating that BH3 proteins can induce
mitochondrial fragmentation without cytochrome c release in the
presence of BAX/BAK inhibition by a pro-survival protein [12].
The mechanism responsible for the activation of mitochondrial
fission and its regulation is still not fully understood [4]. However, it
is appreciated that the activation of the fission protein DRP1 is
increased under apoptotic conditions [6,7]. The fact that BAX and
BAK deficient cells can still undergo fission [11] suggests that the
BAX and BAK are dispensable for initiating mitochondrial fission.
By contrast, BAX and BAK proteins play important roles in the
normal morphogenesis of the mitochondria by activating assembly
of the fusion GTPase, Mfn2, thereby promoting fusion of the
mitochondria [35]. However, we did not find that loss of BAX and
BAK altered mitochondrial morphology or dynamics under normal
cell culture conditions (Movie S1) compared with wild-type cells
(Movie S2). Bid BH3 peptide altered mitochondrial morphology
and dynamics (Movies S3) compared to mutant BH3 peptide
(Movie S3 and Movie S4). Interestingly, we could not rescue
mitochondrial fission by a dominant negative Drp1 or mdivi-1, a
pharmacological inhibitor of mitochondrial fission. Since the
process of mitochondrial fission is not fully understood [14], we
cannot exclude the possibility that unidentified regulator(s) of fission
might be responsible for cell death in the absence of BAX/BAK in
the presence of BH3 peptides. Much of the previous work has
primarily focused on the regulationofmitochondrialfission byBAX
and BAK and not by the pro-survival BCL-2 proteins. A recent
study did demonstrate that the pro-survival protein BCL-XL binds
to DRP1 which leads to an increase in the GTPaseactivity of DRP1
[27]. We also observed that DRP1 coimmunoprecipitates with
BCL-XL. Moreover, this interaction between the two proteins was
increased when BH3 peptide was added to the cells. Our current
findings, however, does not distinguish whether the BH3 peptide
binding to pro-survival proteins is permissive for mitochondrial
fission to occur, or whether the BH3 binding to pro-survival protein
directly promotes mitochondrial fission.
The physiological implication of our findings presently remains
unknown. The BAX and BAK deficient animals are not
embryonic lethal and do not display severe developmental defects
[36] when compared to BCL-XL, MCl-1 or caspase-9, deficient
animals which all display severe developmental defects [37–39].
The mechanism by which cells undergo developmental cell death
in the absence of BAX and BAK remains unknown. But it suggests
that there are other death mechanisms initiated during develop-
ment in the absence of BAX and BAK to obtain viable mice. We
speculate that BH3 proteins engage prosurvival BCL-2 proteins to
trigger mitochondrial fission and cell death in the absence of BAX
and BAK during development. The mitochondrial fission results in
dysfunctional mitochondria which could trigger cell death in the
absence of BAX/BAK. In summary our data provide evidence
that pro-survival proteins can regulate mitochondrial fission and
death in the absence of BAX and BAK.
Methods
Cell lines
Wild type and Bax
2/2/Bak
2/2 mouse embryonic fibroblasts
were kindly provided by Dr. Craig Thompson. Wild type and
Bax
2/2/Bak
2/2 Baby mouse kidney epithelial cells were kindly
provided by Dr. Eileen White. Cells were cultured in Dulbecco’s
modified essential media (DMEM), supplemented with 10% heat-
inactivated Fetal Bovine Serum (FBS), 100 U/ml penicillin,
100 mg/ml streptomycin and 20 mM Hepes. All cell culture
reagents were purchased from GIBCO.
Peptides
Peptides containing 8 D-arginine were synthesized by Tufts
University Core Facility and purified by HPLC. The N-terminus
and C-terminus of the peptides were blocked by an acetyl and
amide group respectively. Peptide sequences are the following:
BID BH3: EDIIRNIARHLAQVGDSMDR,
Mutant BID BH3: EDIIRNIARHAAQVGASMDR,
BIM BH3: MRPEIWIAQELRRIGDEFNA,
BAD BH3: LWAAQRYGRELRRMSDEFEGSFKGL,
Mutant BAD BH3: LWAAQRYGREARRMSAEFEGSFK-
GL,
NOXA A BH3: AELPPEFAAQLRKIGDKVYC,
NOXA B BH3: PADLKDECAQLRRIGDKVNL
Measurement of cell death
Cell death was assessed by the release of lactate dehydrogenase
(LDH) into the surrounding medium using a cytotoxicity detection
kit from Roche Applied Science. Percentage of cell death was
calculated by the amount of LDH released in the medium, divided
by the total LDH released after treatment of cells with 1% Triton
X-100. Flow cytometry was also used to detect PI positive cells
stained according to manufacture’s protocol (BD Biosciences).
Immunoblot Analysis
Protein expression was analyzed in total cell by lysing cells with
16 cell lysis buffer (Cell Signaling) supplemented with 1 mM
phenylmethylsulfonyl fluoride. Protein concentration was deter-
mined using the Bio-Rad protein assay. 50 mg of total cell lysate
were resolved on a 10% or 12% sodium dodecyl sulfate-
polyacrylamide gel (Bio-Rad) and transferred to a Hybond-ECL
nitrocellulose membrane (Amersham). Membranes were blocked
in 5% milk in Tris-buffered saline-Tween 20 buffer. Primary
antibodies used were Bok antibody (Cell signaling), Bcl-XL
antibody (Santa cruz), DRP1 antibody (H-300, sc 32898), Flag
antibody (Sigma), Cytochrome c antibody (Mitosciences), COX-1
antibody (BD Pharmingen) and alpha-tubulin antibody (Sigma
clone B-5-1-2) at 1:2,000. Secondary antibodies used were
horseradish peroxidase-linked anti-mouse or anti-rabbit IgG (Cell
Signaling) 1:1000. SuperSignal chemiluminescent substrate
(Pierce) was used to develop the blot. A representative blot is
shown above of three independent experiments.
Live cell imaging
Cytochrome c release was monitored using cytochrome c tagged
with GFP. Mitochondrial membrane depolarization was assessed
BAX/BAK Independent Cell Death
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Mitotracker CMX-ROS (Invitrogen) counterstain. Dynamic live
cell imaging was performed on a Yokogawa spinning disc confocal
fitted on a Nikon TE2000U microscope enclosed in 37C heated
CO2 chamber, housed at the Northwestern University Cell
Imaging Facility. Image acquisition was performed by Hama-
matsu 9100C electron-multiplication CCD camera through a
1006 objective lens (N.A. 1.46). Care was taken during image
acquisition to ensure that there were no saturated pixels. Image
analysis was performed by MetaMorph (version 6.3r5) software.
The release of TMRE upon membrane depolarization caused a
decrease in intramitochondrial fluorescent intensity. To track the
time-dependent TMRE fluorescent intensity changes, a region was
drawn along the cell outline. This region was then transposed to a
cell-free region in the same field of view adjacent to the cell being
imaged. To obtain the mitochondrial/diffuse index, the intensity
standard deviation [40] within these two regions was ratiome-
trically compared over time as: (ICell 2 IBackground)/IBackground;
wherein ICell represents the intensity standard deviation of within
the region outlining the cell, and IBackground represents the intensity
standard deviation within the exact same region transposed to a
cell-free area. The mitochondria/diffuse index thus allowed us to
simultaneously correct for background fluorescence fluctuations
and track TMRE release.
Mitochondrial Transition Pore Assay
To assess for the mitochondrial transition pore opening, Bax
2/2/
Bak
2/2 MEFs were treated with corresponding BH3 peptides for
1 hour, trypsinized and labeled for flow cytometry using MitoPro-
be
TM Transition Pore Assay Kit (Invitrogen) according to manufac-
ture’s protocol. The change in mean Calcein fluorescence of the
mitochondria before and after addition of ionomycin indicates
activation of the mitochondrial permeability transition pore.
Mitochondria isolation and cytochrome c release
Wild type or Bax
2/2/Bak
2/2 MEFs were collected in
mitochondrial isolation buffer (250 mM sucrose, 10 mM Tris-
Hcl pH 7.4, 0.1 mM EGTA. Mitochondria were obtained by
mechanical cell disruption using a dounce homogenizer followed
by 10 expulsions through a 27 gauge syringe and differential
centrifugation. Isolated mitochondria were then re-suspended in
experimental buffer (125 mM KCl, 10 mM Tris-MOPs, 5 mM
glutamate, 2.5 mM malate, 1 mM KPO, 10 uM EGTA-Tris), and
incubated with appropriate peptides for 30 minutes at room
temperature. Cytochrome c release was assessed by ELISA using a
mouse cytochrome c immunoassay from R& D Systems. As a
control to assess for total (100%) cytochrome c release, isolated
mitochondria were treated with 0.5% Tx-100 (Sigma) while the
minimum value is cytochrome c release from cells treated with
DMSO. Percentage cytochrome c release was calculated accord-
ing to the following equation: %cyto c=(X-min cyto c)/(Total
cyto c- min cyto c), whereby X is the value obtain for each
experimental condition.
Retroviral transfection
Packaging cell line PLAT-E (kind gift of T. Kitamura) were
transfected using Mirus TransIT Transfection reagent (Mirus Bio
Corporation) according to the manufacturer’s protocol. 48 hours
post transfection, medium containing virus was supplemented with
8 mg/ml polybrene (Sigma) for cell line infection and applied to
MEFs. The pSiren vector (Clontech) was used to express short
hairpin RNA (shRNA) sequences for Bok (59-CAGATCCGTCC-
CAGCGTAT-39) and Drosophila melanogaster HIF (dHIF) (59-
GCCTACATCCCGATCGATGATG-39). Cytochrome c GFP
construct was a kind gift from Dr. D.R. Green. DN-Drp-1
construct was a kind gift from Dr. R. Youle, which we re-cloned
into pBabe GFP. Infected cells were selected with corresponding
selection markers, and for GFP expressing cells, selection was
achieved by sorting using the DakoCytomation MoFlo high speed
multilaser droplet cell sorter at 488 nm.
Electron Microscopy
Treated cells were rinsed with PBS and fixed for 1 hour in 2.5%
glutaraldehyde at room temperature followed by another rinse in
0.1 M cacodylate buffer. Coverslips were then incubated in
secondary fixative of 2% osmium tetroxide for 30 minutes.
Samples were then en-bloc stained with 3% uranyl acetate. Fixed
cells were dehydrated in a graded series of ethanol and embedded
in araldite and epon mixture. Following sectioning, the samples
were contrasted with 6% uranyl acetate and Reynols lead. Images
were taken on the JOEL 1220 Transmission Electron Microscope.
Random cells were chosen for imaging and aspect ratio of all
mitochondria within a cell section were calculated using the
MetaMorph software (version 6.3r5).
Immunoprecipitation
Bcl-xL was immunoprecipitated using the FLAGH Tagged
Protein Immunoprecipitation Kit (Sigma) per manufacturer’s
protocol. Briefly, Bax
2/2/Bak
2/2 MEFs overexpressing FLAG-
Bcl-xL were plated in 10 cm plates. At 50% confluency, cells were
treated with 100 mM of BID or mutant BID BH3 peptide for
10 minutes. Cells were washed in PBS and Cell Lysis Buffer
(50 mM Tris HCl, pH 7.4, with 150 mM NaCl, 1 mM EDTA,
and 1% TRITON
TM X-100) was added. Total protein was
determined by Bradford Assay. Flag tagged Bcl-XL were
immunoprecipiated with ANTI-FLAG M2 affinity gel. Equal
protein was added to the gel and incubated overnight on a roller
shaker at 4uC. Immunoprecipitates were separated on 12% poly-
acrilimide gels and detected using anti-DRP1 antibody (H-300,
Santa Cruz Biotechnology, 1:200) and Flag antibody (Sigma) as
loading control.
Microinjection
Bax
2/2/Bak
2/2 MEFs were microinjected with BID or mutant
BID peptide that does not contain 8D-arginine sequence. The
peptides were dissolved in 10 mM Tris and Dextran FITC was
added as a marker for identification of injected cells. Microinjec-
tion was carried out on an Axovert 135 microscope equipped with
an Ependorf Femtojet microinjector. Cells were injected using
Femtotip II injection capillary at a pressure of 22 hPa. Injected
cells were viewed 30 minutes following injection using a
fluorescence microscope LSM510 and pictures were captured
using a 636lens objective.
Other reagents
MDIVI compound was purchased from Ryan Scientific and
was resuspended in DMSO. 3-Methyladenine, staurosporine, and
cyclosporin A were purchased from Sigma Aldrich. Q-VD-OPh
was purchased from R&D Scientific. Mitotracker CMX-ROS and
tetramethylrhodamine ethyl ester (TMRE) were purchased from
Invitrogen.
Supporting Information
Figure S1 FITC tagged peptide uptake in Bax2/2/Bak2/2
MEFs. (A) Bax2/2/Bak2/2 MEFs treated with DMSO, (B)
100 mM mutant BID or (C) 100 mM BID BH3 peptides that were
BAX/BAK Independent Cell Death
PLoS ONE | www.plosone.org 14 May 2009 | Volume 4 | Issue 5 | e5646tagged to FITC for 5 minutes. Flow cytometry was performed to
assess for GFP positive cells.
Found at: doi:10.1371/journal.pone.0005646.s001 (0.53 MB TIF)
Figure S2 Bax2/2/Bak2/2 MEFs overexpressing BCL-XL
are not protected against peptide induce cell death. (A) LDH
release of Bax2/2/Bak2/2 MEFs overexpressing empty
construct or BCL-XL when treated with increasing concentration
of BID or mutant BID BH3 peptide at 24 hours. Mean
values6SEMs of 3 independent experiments are shown. (B)
Western Blot analysis of whole cell lysate of Bax2/2/Bak2/2
MEFs, overexpressing empty construct or BCL-XL.
Found at: doi:10.1371/journal.pone.0005646.s002 (0.69 MB TIF)
Figure S3 CsA inhibits the permeability transition pore of
Bax2/2/Bak2/2 MEFs. Bax2/2/Bak2/2 MEFs were
loaded with Calcein AM in the presence of cobolt choride for
mitochondria labeling. Following mitochondrial Calcein uptake,
only cells that were treated with CsA allowed for Calcein retention
following treatment with ionomycin.
Found at: doi:10.1371/journal.pone.0005646.s003 (0.50 MB TIF)
Movie S1 Bax/Bak Null MEFs Mitotracker Red
Found at: doi:10.1371/journal.pone.0005646.s004 (0.85 MB
MPG)
Movie S2 Wild-type MEFs Mitotracker Red
Found at: doi:10.1371/journal.pone.0005646.s005 (1.75 MB
MPG)
Movie S3 Bax/Bak Null MEFs+Bid BH3peptide Mitotracker
Red
Found at: doi:10.1371/journal.pone.0005646.s006 (0.63 MB
MPG)
Movie S4 Bax/Bak null MEFs+mutant BH3 peptide Mito-
tracker Red
Found at: doi:10.1371/journal.pone.0005646.s007 (0.50 MB
MPG)
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